Validation of trabectedin efficacy in patients with advanced soft tissue sarcoma

Dr Axel Le Cesne, oncologist, sarcoma expert at Gustave Roussy, presents at ASCO 2018 the results of the T-SAR trial, comparing trabectedin vs best supportive care in patients with pretreated advanced soft tissue sarcoma.

• قسم